No.11589428 ViewReplyOriginalReport
Remicade, a drug used frequently by Crohn's disease patients, has been shown to reduce the effects of COVID on a patient's lungs.

Basically what happens is that since Remicade is an immunosupressent, it will allow reduce the capacity of the immune system to damage the lungs over time.

What does /sci/ think of this?